LIBERATE Intervention for Type 2 Diabetes

St. Joseph's Family Medical and Dental Centre, London, Canada
LIBERATEN/ARecruitingLed by Sonja M Reichert, MDResearch Sponsored by Western University, Canada

Study Summary

This trialwill test a 6-month program, with bi-weekly group classes and weekly communication, to help people with diabetes manage their health through nutrition and exercise.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You have never used a Flash glucose monitor before but you are interested in trying this technology.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c from Baseline
Secondary outcome measures
Change in rapid insulin use from Baseline
Change in total daily basal insulin use from baseline
Other outcome measures
Anthropometric: Change in Height from baseline
Anthropometric: Change in Waist circumference from baseline
Anthropometric: Change in Weight from baseline
+19 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: LIBERATE InterventionExperimental Treatment1 Intervention

Find a site

Who is running the clinical trial?

Abbott Diabetes CareIndustry Sponsor
61 Previous Clinical Trials
24,393 Total Patients Enrolled
Western University, CanadaLead Sponsor
218 Previous Clinical Trials
39,598 Total Patients Enrolled
Sonja M Reichert, MDPrincipal Investigator
Western University

Media Library

LIBERATE Clinical Trial Eligibility Overview. Trial Name: NCT05261906 — N/A
Type 2 Diabetes Research Study Groups: LIBERATE Intervention
Type 2 Diabetes Clinical Trial 2023: LIBERATE Highlights & Side Effects. Trial Name: NCT05261906 — N/A
LIBERATE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05261906 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study still recruiting participants?

"Affirmative.'s records inform us that the enrollment window for this clinical trial is open, and it was first posted on September 26th 2022 before being updated on October 7th 2022. 184 participants are required from 1 site to complete the study."

Answered by AI

What is the maximum number of enrollees for this scientific investigation?

"Affirmative. Data provided on says that this research project is currently requiring participants, with the first posting occuring on September 26th 2022 and last amendment happening October 7th 2022. In total, 184 people are being welcomed at 1 site for participation in this study."

Answered by AI
~84 spots leftby Oct 2024